📰 Iprd Development Milestones News
Iprd Development Milestones News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iprd Development Milestones. Real-time updates on events, politics, business and more.
December 13, 2022
Lilly expects to deliver strong financial and operational performance in 2023, highlighted by volume-driven revenue growth; potential launches for donanemab,...
November 1, 2022
Lillys revenue in Q3 2022 increased 2%, or 7% on a constant currency basis, primarily driven by volume growth of key growth products, partially offset by...
August 4, 2022
Lillys revenue in Q2 2022 decreased 4%. On a constant currency basis, revenue decreased 1% as lower realized prices and lower Alimta revenue following the...
April 28, 2022
Lillys revenue growth in Q1 2022 increased 15%, driven by volume growth of 20%. Excluding revenue from COVID-19 antibodies and Alimta, Q1 2022 revenue grew...
April 28, 2022
Lillys revenue growth in Q1 2022 increased 15%, driven by volume growth of 20%. Excluding revenue from COVID-19 antibodies and Alimta, Q1 2022 revenue grew...